MedPal AI (LSE:MPAL) Debt-to-Asset : 0.32 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI Debt-to-Asset?

MedPal AI LSE:MPAL -4.76% Debt-to-Asset is 0.32 as of Feb. 2026. The stock has 1 warning sign investors should review.

MedPal AI's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was £0.37 Mil. MedPal AI's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2026 was £0.38 Mil. MedPal AI's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Feb. 2026 was £2.32 Mil. MedPal AI's debt to asset for the quarter that ended in Feb. 2026 was 0.32.


MedPal AI  (LSE:MPAL) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


MedPal AI Debt-to-Asset Related Terms


MedPal AI Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for MedPal AI's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI Debt-to-Asset Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
Debt-to-Asset
0.00 0.00 0.00 0.00

MedPal AI Semi-Annual Data
Feb24 Aug24 Feb25 Aug25 Feb26
Debt-to-Asset 0.00 0.00 0.00 0.00 0.32

LSE:MPAL vs VEEV, BTSG, TEM: Debt-to-Asset Comparison

For the Health Information Services subindustry, MedPal AI's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedPal AI Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where MedPal AI's Debt-to-Asset falls into.



MedPal AI Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

MedPal AI's Debt-to-Asset for the fiscal year that ended in Aug. 2025 is calculated as

MedPal AI's Debt-to-Asset for the quarter that ended in Feb. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0.366712 + 0.377692) / 2.321834
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.32 mean?
MedPal AI (LSE:MPAL) has a Debt-to-Asset of 0.32 as of Feb. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on MedPal AI and its competitors.
Is MedPal AI's Debt-to-Asset too high?
MedPal AI's current Debt-to-Asset is 0.32.
How does MedPal AI's Debt-to-Asset compare to VEEV and BTSG?
MedPal AI's Debt-to-Asset of 0.32 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on MedPal AI and its competitors. MedPal AI's current Debt-to-Asset is 0.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Debt-to-Asset of 0.32. The current Debt-to-Asset is 0.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Debt-to-Asset is 0.32 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.